Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer

Doriana Morichetti, Alfredo Santinelli, Marina Scarpelli, Aldo V. Bono, Antonio Lopez-Beltran, Liang Cheng, Roberta Mazzucchelli

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: The aim was to examine the expression and localization of the five somatostatin receptors (termed SSTR1-5) in radical prostatectomies (RPs) from patients with prostatic adenocarcinoma (PCa) under complete androgen ablation (CAA) before operation. Material: The five SSTRs were evaluated in the epithelial, smooth muscle and endothelial cells of normal-looking epithelium (Nep), high-grade prostatic intraepithelial neoplasia (HGPIN) and PCa in 20 RPs with clinically detected PCa from patients under CAA. 20 RPs with clinically detected PCa from hormonally untreated patients were used as control group. Results: Concerning the secretory cells (i) membrane staining was seen for SSTR3 and SSTR4; the mean percentages of positive cells, higher in SSTR3 than in SSTR4, decreased sharply in HGPIN and PCa compared with Nep; the mean percentages in the androgen ablated group were 30-90% lower than in the untreated; (ii) cytoplasmic staining was seen for all 5 SSTRs; the mean percentages of positive cells in Nep, HGPIN and PCa of the untreated group were similar, and in general as high as 80% or more; in the treated group, the Nep values were similar to those in the untreated, whereas the values in HGPIN and PCa were lower for SSTR1, 3 and 5, with a decrease of 30% for SSTR1; (iii) nuclear staining was seen with SSTR4 and SSTR5, the mean percentages for the former being much lower than for the latter; treatment affected both HGPIN and PCa, whose proportions of stained cells were 30-55% lower than in the untreated group. Cytoplasmic staining in the basal cells was seen for all 5 SSTRs, both in Nep and HGPIN. The values in the treated group were lower than in the other, the difference between the two group being in general comprised between 10 and 40%. Treatment did not affect SSTR staining in the smooth muscle and endothelial cells. Conclusions: The present study expands our knowledge on the expression and localization of the five SSTRs in the prostate following CAA.

Original languageEnglish
Pages (from-to)27-36
Number of pages10
JournalAnalytical Cellular Pathology
Volume33
Issue number1
DOIs
StatePublished - 2010

Fingerprint

Somatostatin Receptors
Prostatic Intraepithelial Neoplasia
Androgens
Prostatic Neoplasms
Adenocarcinoma
Epithelium
Staining and Labeling
Prostatectomy
Smooth Muscle Myocytes
Endothelial Cells
Prostate
Cell Membrane
Control Groups
Therapeutics

Keywords

  • complete androgen ablation
  • high-grade prostatic intraepithelial neoplasia
  • prostate cancer
  • Somatostatin receptors

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer. / Morichetti, Doriana; Santinelli, Alfredo; Scarpelli, Marina; Bono, Aldo V.; Lopez-Beltran, Antonio; Cheng, Liang; Mazzucchelli, Roberta.

In: Analytical Cellular Pathology, Vol. 33, No. 1, 2010, p. 27-36.

Research output: Contribution to journalArticle

Morichetti, Doriana ; Santinelli, Alfredo ; Scarpelli, Marina ; Bono, Aldo V. ; Lopez-Beltran, Antonio ; Cheng, Liang ; Mazzucchelli, Roberta. / Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer. In: Analytical Cellular Pathology. 2010 ; Vol. 33, No. 1. pp. 27-36.
@article{2a6282176399498cba1bfa473ee316ee,
title = "Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer",
abstract = "Objective: The aim was to examine the expression and localization of the five somatostatin receptors (termed SSTR1-5) in radical prostatectomies (RPs) from patients with prostatic adenocarcinoma (PCa) under complete androgen ablation (CAA) before operation. Material: The five SSTRs were evaluated in the epithelial, smooth muscle and endothelial cells of normal-looking epithelium (Nep), high-grade prostatic intraepithelial neoplasia (HGPIN) and PCa in 20 RPs with clinically detected PCa from patients under CAA. 20 RPs with clinically detected PCa from hormonally untreated patients were used as control group. Results: Concerning the secretory cells (i) membrane staining was seen for SSTR3 and SSTR4; the mean percentages of positive cells, higher in SSTR3 than in SSTR4, decreased sharply in HGPIN and PCa compared with Nep; the mean percentages in the androgen ablated group were 30-90{\%} lower than in the untreated; (ii) cytoplasmic staining was seen for all 5 SSTRs; the mean percentages of positive cells in Nep, HGPIN and PCa of the untreated group were similar, and in general as high as 80{\%} or more; in the treated group, the Nep values were similar to those in the untreated, whereas the values in HGPIN and PCa were lower for SSTR1, 3 and 5, with a decrease of 30{\%} for SSTR1; (iii) nuclear staining was seen with SSTR4 and SSTR5, the mean percentages for the former being much lower than for the latter; treatment affected both HGPIN and PCa, whose proportions of stained cells were 30-55{\%} lower than in the untreated group. Cytoplasmic staining in the basal cells was seen for all 5 SSTRs, both in Nep and HGPIN. The values in the treated group were lower than in the other, the difference between the two group being in general comprised between 10 and 40{\%}. Treatment did not affect SSTR staining in the smooth muscle and endothelial cells. Conclusions: The present study expands our knowledge on the expression and localization of the five SSTRs in the prostate following CAA.",
keywords = "complete androgen ablation, high-grade prostatic intraepithelial neoplasia, prostate cancer, Somatostatin receptors",
author = "Doriana Morichetti and Alfredo Santinelli and Marina Scarpelli and Bono, {Aldo V.} and Antonio Lopez-Beltran and Liang Cheng and Roberta Mazzucchelli",
year = "2010",
doi = "10.3233/ACP-CLO-2010-0529",
language = "English",
volume = "33",
pages = "27--36",
journal = "Analytical Cellular Pathology",
issn = "2210-7177",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer

AU - Morichetti, Doriana

AU - Santinelli, Alfredo

AU - Scarpelli, Marina

AU - Bono, Aldo V.

AU - Lopez-Beltran, Antonio

AU - Cheng, Liang

AU - Mazzucchelli, Roberta

PY - 2010

Y1 - 2010

N2 - Objective: The aim was to examine the expression and localization of the five somatostatin receptors (termed SSTR1-5) in radical prostatectomies (RPs) from patients with prostatic adenocarcinoma (PCa) under complete androgen ablation (CAA) before operation. Material: The five SSTRs were evaluated in the epithelial, smooth muscle and endothelial cells of normal-looking epithelium (Nep), high-grade prostatic intraepithelial neoplasia (HGPIN) and PCa in 20 RPs with clinically detected PCa from patients under CAA. 20 RPs with clinically detected PCa from hormonally untreated patients were used as control group. Results: Concerning the secretory cells (i) membrane staining was seen for SSTR3 and SSTR4; the mean percentages of positive cells, higher in SSTR3 than in SSTR4, decreased sharply in HGPIN and PCa compared with Nep; the mean percentages in the androgen ablated group were 30-90% lower than in the untreated; (ii) cytoplasmic staining was seen for all 5 SSTRs; the mean percentages of positive cells in Nep, HGPIN and PCa of the untreated group were similar, and in general as high as 80% or more; in the treated group, the Nep values were similar to those in the untreated, whereas the values in HGPIN and PCa were lower for SSTR1, 3 and 5, with a decrease of 30% for SSTR1; (iii) nuclear staining was seen with SSTR4 and SSTR5, the mean percentages for the former being much lower than for the latter; treatment affected both HGPIN and PCa, whose proportions of stained cells were 30-55% lower than in the untreated group. Cytoplasmic staining in the basal cells was seen for all 5 SSTRs, both in Nep and HGPIN. The values in the treated group were lower than in the other, the difference between the two group being in general comprised between 10 and 40%. Treatment did not affect SSTR staining in the smooth muscle and endothelial cells. Conclusions: The present study expands our knowledge on the expression and localization of the five SSTRs in the prostate following CAA.

AB - Objective: The aim was to examine the expression and localization of the five somatostatin receptors (termed SSTR1-5) in radical prostatectomies (RPs) from patients with prostatic adenocarcinoma (PCa) under complete androgen ablation (CAA) before operation. Material: The five SSTRs were evaluated in the epithelial, smooth muscle and endothelial cells of normal-looking epithelium (Nep), high-grade prostatic intraepithelial neoplasia (HGPIN) and PCa in 20 RPs with clinically detected PCa from patients under CAA. 20 RPs with clinically detected PCa from hormonally untreated patients were used as control group. Results: Concerning the secretory cells (i) membrane staining was seen for SSTR3 and SSTR4; the mean percentages of positive cells, higher in SSTR3 than in SSTR4, decreased sharply in HGPIN and PCa compared with Nep; the mean percentages in the androgen ablated group were 30-90% lower than in the untreated; (ii) cytoplasmic staining was seen for all 5 SSTRs; the mean percentages of positive cells in Nep, HGPIN and PCa of the untreated group were similar, and in general as high as 80% or more; in the treated group, the Nep values were similar to those in the untreated, whereas the values in HGPIN and PCa were lower for SSTR1, 3 and 5, with a decrease of 30% for SSTR1; (iii) nuclear staining was seen with SSTR4 and SSTR5, the mean percentages for the former being much lower than for the latter; treatment affected both HGPIN and PCa, whose proportions of stained cells were 30-55% lower than in the untreated group. Cytoplasmic staining in the basal cells was seen for all 5 SSTRs, both in Nep and HGPIN. The values in the treated group were lower than in the other, the difference between the two group being in general comprised between 10 and 40%. Treatment did not affect SSTR staining in the smooth muscle and endothelial cells. Conclusions: The present study expands our knowledge on the expression and localization of the five SSTRs in the prostate following CAA.

KW - complete androgen ablation

KW - high-grade prostatic intraepithelial neoplasia

KW - prostate cancer

KW - Somatostatin receptors

UR - http://www.scopus.com/inward/record.url?scp=79960752018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960752018&partnerID=8YFLogxK

U2 - 10.3233/ACP-CLO-2010-0529

DO - 10.3233/ACP-CLO-2010-0529

M3 - Article

C2 - 20966542

AN - SCOPUS:79960752018

VL - 33

SP - 27

EP - 36

JO - Analytical Cellular Pathology

JF - Analytical Cellular Pathology

SN - 2210-7177

IS - 1

ER -